Literature DB >> 9228516

Adrenal functions in patients with sepsis.

B Aygen1, M Inan, M Doğanay, F Keleştimur.   

Abstract

The basal cortisol level and cortisol response to ACTH stimulation test were assessed in patients with sepsis, the results being compared to a control group of 30 healthy persons. The study group included 49 patients with sepsis and 30 healthy subjects as a control group. The mean age in the study group was 42.6 +/- 18.7 years and 41.4 +/- 12.1 years in the control group. Fifteen of the 49 (30.6%) patients had hospital-acquired and 34 (69.4%) patients community-acquired sepsis. Etiological agent was isolated in 35 (71.4%) patients (57.1% gram negative bacteria and 34.3% gram positive bacteria, plus 8.6% polymicrobial). Fourteen of 49 (28.6%) patients died. Mean basal cortisol level was 597.1 +/- 304.6 nmol/l (range 217.8-1667.9) in the study group and 460.2 +/- 180.8 nmol/l (range 253.6-988.9) in the control group. Mean basal cortisol level in the study group was significantly higher than that of the control group (p < 0.05). Mean basal cortisol level was found to be 725.5 +/- 448.9 nmol/l in the patients who died and 545.8 +/- 210.9 nmol/l in the patients who recovered. The difference between the two groups was found to be significant (p < 0.05). ACTH stimulation test was performed in 43 of the patients and 30 healthy subjects. Cortisol response was significantly lower (mean 277.7 +/- 216.9 nmol/l) in the patients than that detected in the control group (mean 519.6 +/- 279.2) (p < 0.001). Mean cortisol response in the patients who died was 227.2 +/- 224.5 nmol/l and 302.1 +/- 212.7 nmol/l in the patients who recovered (p > 0.05). Adrenocortical insufficiency was detected in 16.3% of the patients and 42.9% of these patients died. In conclusion, sepsis is characterized by high basal cortisol level which may show a poor prognosis and a blunted cortisol response to ACTH stimulation. A small percentage of patients with sepsis may develop adrenocortical insufficiency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228516     DOI: 10.1055/s-0029-1211749

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  10 in total

1.  Cortisol changes among patients with septic shock and the relationship to ICU and hospital stay.

Authors:  Sergei Goodman; Charles L Sprung; Daniel Ziegler; Yoram G Weiss
Journal:  Intensive Care Med       Date:  2005-09-07       Impact factor: 17.440

Review 2.  What is the rationale for hydrocortisone treatment in children with infection-related adrenal insufficiency and septic shock?

Authors:  Rajesh Aneja; Joseph A Carcillo
Journal:  Arch Dis Child       Date:  2006-09-26       Impact factor: 3.791

3.  The Effect of Mesenchymal Stromal Cells on the Mortality of Patients with Sepsis and Septic Shock: A Promising Therapy.

Authors:  Emine Alp; Zeynep Burcin Gonen; Kursat Gundogan; Aliye Esmaoglu; Leylagul Kaynar; Aysun Cetin; Musa Karakukcu; Mustafa Cetin; Gamze Kalin; Mehmet Doganay
Journal:  Emerg Med Int       Date:  2022-06-24       Impact factor: 1.621

Review 4.  Systemic illness.

Authors:  Marta Bondanelli; Maria Chiara Zatelli; Maria Rosaria Ambrosio; Ettore C degli Uberti
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 5.  The hypothalamic-pituitary-adrenal axis in critical illness.

Authors:  Shekhar Venkataraman; Ricardo Munoz; Cristina Candido; Selma Feldman Witchel
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

6.  Evidence of altered cortisol metabolism in critically ill patients: a prospective study.

Authors:  Bala Venkatesh; Jeremy Cohen; Ingrid Hickman; Janelle Nisbet; Peter Thomas; Gregory Ward; Jonathan Hall; John Prins
Journal:  Intensive Care Med       Date:  2007-06-09       Impact factor: 17.440

7.  The effect of methylprednisolone on treatment in rats with induced sepsis.

Authors:  Riza Aytaç Cetinkaya; Levent Görenek; Omer Coşkun; Can Polat Eyigün; Zeynep Senses; Tayfun Ide; Selim Kiliç
Journal:  Clin Exp Med       Date:  2008-10-30       Impact factor: 3.984

8.  The effects of moderate-dose steroid therapy in sepsis: A placebo-controlled, randomized study.

Authors:  Orhan Yildiz; Fatih Tanriverdi; Serap Simsek; Bilgehan Aygen; Fahrettin Kelestimur
Journal:  J Res Med Sci       Date:  2011-11       Impact factor: 1.852

9.  Comparison of total, salivary and calculated free cortisol levels in patients with severe sepsis.

Authors:  Gulsah Elbuken; Zuleyha Karaca; Fatih Tanriverdi; Kursad Unluhizarci; Murat Sungur; Mehmet Doganay; Fahrettin Kelestimur
Journal:  J Intensive Care       Date:  2016-01-08

10.  Physiological-dose steroid therapy in sepsis [ISRCTN36253388].

Authors:  Orhan Yildiz; Mehmet Doganay; Bilgehan Aygen; Muhammet Güven; Fahrettin Keleştimur; Ahmet Tutuû
Journal:  Crit Care       Date:  2002-04-19       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.